Precision Biologics, Inc. reports its lead monoclonal antibody, NEO-201, targets circulating human naïve regulatory T cells (Tregs) in both healthy donors and cancer patients. A poster presentation discussing this data will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2024. Poster title: The O-glycan epitope targeting anti-human carcinoma monoclonal antibody (mAb) NEO-201 can also target human regulatory T cells (Tregs) . This study was performed by Drs. Atsushi Tanaka and Shimon Sakaguchi from Osaka University, Japan. Dr. Sakaguchi’s group independently analyzed by flow cytometry the ability of NEO-201 to recognize naïve Tregs in peripheral blood mononuclear cells (PBMCs) from healthy donors, confirming findings from Precision Biologics in PBMCs from cancer patients. In this study, human PBMCs were collected from 7 healthy donors (HD) at Osaka University and 6 cancer patients from Precision Biologics ongoing phase II… 

ASPYRE-Lung schließt kritische Lücken bei NGS-basierten Biomarker-Tests: Aktuelle abstrakte Daten zeigen, dass 98 % der NGS-QC-Fehler behoben werden können. https://www.abstractsonline.com/pp8/#!/20272/presentation/10387

The 96th National Congress will be held in L’Aquila, from 25 to 28 April 2024, at the Palazzo dell’Emiciclo, headquarters of the Regional Council of the Abruzzo Region (in via Michele Iacobucci, 4), as approved by our Board of Directors. The location of the Palazzo dell’Emiciclo is central and strategic, reachable on foot from hotels, B&Bs, and holiday homes in the center. The main monuments and places of interest in L’Aquila are in fact all located in the historic center. The official language of the congress will, as always, be Italian. The scheduled sessions will be in sequence to allow everyone to follow the scientific works. There will be masterly readings with prestigious speakers. If the contributions received do not allow everyone to have space for oral communication, one or more video poster sessions will also be organized. The scientific… 

Am 18. und 19. April 2024 wird das Texas Cardiac Arrhythmia Institute (TCAI) am St. David’s Medical Center sein siebtes internationales Symposium über komplexe Herzrhythmusstörungen, EPLive 2024, ausrichten. EPLive ist eine intensive, zweitägige Fortbildungsveranstaltung für Ärzte, Krankenschwestern und -pfleger, die sich mit der Behandlung komplexer Herzrhythmusstörungen befassen, bei denen das Herz in einem unregelmäßigen oder abnormen Rhythmus schlägt. Live-Fälle, die mit Expertenkommentaren aus dem hochmodernen elektrophysiologischen Zentrum im St. David’s Medical Center übertragen werden, dienen als primäres Lehrmittel.

The European Lung Cancer Congress 2024 is the annual appointment that brings together various experts in the field of thoracic oncology, including thoracic surgeons, respiratory physicians and pneumologists, medical and radiation oncologists, interventional radiologists and pathologists, to discuss the latest insights into the recent developments in the prevention, diagnosis and treatment of lung cancer. The event will take place in Prague, Czech Republic, and through a dedicated virtual platform between 20-23 March. Programme highlights Novel results in the treatment of EGFR-mutant non-small cell lung cancerRelated content: 3MO, 5MO, 8P, 4O Insights into the opportunities related to the use of immunotherapy, and the challenges related to IO resistance mechanisms that may occur in the treatment of patients with lung cancerRelated content: Sessions on 20 March, 14:30-16:00 CET and 16:30-18:00 CET, session on 21 March, 11:15-12:45 CET Prevention, screening and early diagnosis… 

The Redox Medicine Society (RMS) is pleased to announce the 26th International Conference of the Redox Medicine, taking place from June 27 to June 28, 2024, in Paris, France. Redox Medicine 2024 will gather the world’s leading experts in redox biology, signaling pathways, and their impact on medicine, promising to highlight the current and future state of Redox Medicine. Among the Speakers & Topics Bruce Freeman, University of Pittsburgh, USA – “Electrophilic Small Molecule Nitroalkenes as Multi-Target Anti-Inflammatory Drugs” Mario D. Cordero, Universidad Pablo de Olavide, Spain – “Mechanism of the SuperInflammasome Complexes in Human Diseases and Redox Signaling” Christel Marquette, Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA), France – „Neuroinflammation, Alzheimer’s Disease and Cell Death: Role of Redox“ Zaher El Beck, Karolinska Institutet, Sweden – “Epigenetic Modulators Link Mitochondrial Redox Homeostasis to Cardiac Function” Tamara Tomin, TU…